PL1768673T3 - Kompozycja farmaceutyczna rozpadająca się w ustach obejmująca risperidon - Google Patents

Kompozycja farmaceutyczna rozpadająca się w ustach obejmująca risperidon

Info

Publication number
PL1768673T3
PL1768673T3 PL05757277T PL05757277T PL1768673T3 PL 1768673 T3 PL1768673 T3 PL 1768673T3 PL 05757277 T PL05757277 T PL 05757277T PL 05757277 T PL05757277 T PL 05757277T PL 1768673 T3 PL1768673 T3 PL 1768673T3
Authority
PL
Poland
Prior art keywords
risperidone
pharmaceutical composition
orally disintegrating
disintegrating pharmaceutical
orally
Prior art date
Application number
PL05757277T
Other languages
English (en)
Inventor
Vesna; Kroselj
Tadeja Rajer
Marija; Rangus
Jozica Gustin
Original Assignee
Krka Tovarna Zdravil D D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil D D filed Critical Krka Tovarna Zdravil D D
Publication of PL1768673T3 publication Critical patent/PL1768673T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL05757277T 2004-06-15 2005-06-14 Kompozycja farmaceutyczna rozpadająca się w ustach obejmująca risperidon PL1768673T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004028940A DE102004028940A1 (de) 2004-06-15 2004-06-15 Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
PCT/EP2005/006375 WO2005123084A1 (en) 2004-06-15 2005-06-14 Orally disintegrating pharmaceutical composition comprising risperidone
EP05757277A EP1768673B1 (en) 2004-06-15 2005-06-14 Orally disintegrating pharmaceutical composition comprising risperidone

Publications (1)

Publication Number Publication Date
PL1768673T3 true PL1768673T3 (pl) 2009-01-30

Family

ID=34971693

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05757277T PL1768673T3 (pl) 2004-06-15 2005-06-14 Kompozycja farmaceutyczna rozpadająca się w ustach obejmująca risperidon

Country Status (13)

Country Link
EP (1) EP1768673B1 (pl)
AT (1) ATE402706T1 (pl)
DE (2) DE102004028940A1 (pl)
EA (1) EA010178B1 (pl)
ES (1) ES2311230T3 (pl)
HR (1) HRP20080452T3 (pl)
NO (1) NO20070187L (pl)
PL (1) PL1768673T3 (pl)
PT (1) PT1768673E (pl)
RS (1) RS50609B (pl)
SI (1) SI1768673T1 (pl)
UA (1) UA87692C2 (pl)
WO (1) WO2005123084A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
TW200835527A (en) * 2006-12-26 2008-09-01 Shionogi & Co Orally disintegrating tablet and bitter taste-masked formulation comprising risperidone
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
WO2008152729A1 (ja) * 2007-06-15 2008-12-18 Teikokumedix Co., Ltd. リスペリドンを含むゼリー状の医薬組成物
CN101485636B (zh) * 2008-01-14 2010-12-22 齐鲁制药有限公司 利培酮口腔崩解片及其制备方法
WO2013095314A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising risperidone
WO2013100876A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Risperidone formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6224905B1 (en) * 1996-06-17 2001-05-01 Janssen Pharmaceutica N.V. Biconvex rapidly disintegrating dosage forms
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
RU2245136C2 (ru) * 2001-07-27 2005-01-27 Яманоути Фармасьютикал Ко., ЛТД Композиция, включающая тонкодисперсные частицы с замедленным высвобождением для быстроразлагающихся в щечной полости таблеток, и способ ее получения
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
CN1819819B (zh) * 2003-05-07 2011-03-09 株式会社三养社 用于制备速熔片的高度可塑性颗粒
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone

Also Published As

Publication number Publication date
UA87692C2 (ru) 2009-08-10
SI1768673T1 (sl) 2008-12-31
EP1768673A1 (en) 2007-04-04
EA010178B1 (ru) 2008-06-30
PT1768673E (pt) 2008-10-21
NO20070187L (no) 2007-03-02
EA200700023A1 (ru) 2007-06-29
HRP20080452T3 (en) 2008-10-31
ES2311230T3 (es) 2009-02-01
DE102004028940A1 (de) 2006-01-12
ATE402706T1 (de) 2008-08-15
WO2005123084A1 (en) 2005-12-29
DE602005008607D1 (de) 2008-09-11
EP1768673B1 (en) 2008-07-30
RS50609B (sr) 2010-06-30

Similar Documents

Publication Publication Date Title
TW200744602A (en) Administration of dipeptidyl peptidase inhibitors
MX2009001294A (es) Granulo y tableta que se desintegra por vía oral que comprende oxicodona.
HRP20080452T3 (en) Orally disintegrating pharmaceutical composition comprising risperidone
MX2009002772A (es) Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro- 2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo.
AP2007003973A0 (en) Novel dideptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and proces for their preparation
TW200637614A (en) Bendamustine pharmaceutical compositions
UA90875C2 (ru) Лекарственные формы пролонгированного действия, которые содержат ранолазин
SG153800A1 (en) Pharmaceutical compositions
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
IL180872A0 (en) Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
MX343358B (es) Tabletas de acetato de ulipristal.
TN2009000362A1 (en) Weekly administration of dipeptidyl peptidase inhibitors
IL193252A0 (en) N-hydroxyacrylamide compounds
ZA200702418B (en) Taste-masking Pharmaceutical compositions
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
GEP20125458B (en) Matrix metalloproteinase inhibitors
UA94036C2 (ru) Фармацевтическая композиция бендамустина, предназначенная для лиофилизации
UA89201C2 (ru) Энантиомеры выбранных конденсированных пиримидонов и их применение для лечения и профилактики злокачественного новообразования
TW200738649A (en) Calcilytic compounds
GB0406378D0 (en) Novel pharmaceutical compositions
ZA200604874B (en) Pharmaceutical compositions
WO2006005578A3 (en) Solid pharmaceutical composition comprising mirtazapine
MX2009005804A (es) Composicion farmaceutica de memantina.
IL191992A0 (en) Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications